Additionally, we detected fusion genes in 97.6% or BCR-ABL in 90.2% of all CML patients characterized, which is also in good agreement to CML-associated gene fusions reported previously [3]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.